Gut microbiome lab launched at Hyderabad hospital to advance research into IBD

AIG Hospitals in Hyderabad have launched a dedicated Gut Microbiome Therapeutics and Pill Lab to advance research into inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. The lab will focus on developing oral microbiome capsule formulations using scientifically screened donor material, with processes encompassing microbiome profiling, controlled sample processing, preservation, capsule formulation, quality and safety checks, and clinical research protocols.

The hospital clarifies that the microbiome pill is strictly for research purposes and will be used only as part of approved clinical research programmes.

Brief written by urgent.news from The Hindu's own syndicated text. Machine-written — may contain errors; check the original before relying on it.